Viking Therapeutics, Inc. (LON:0VQA)

Viking Therapeutics Statistics

Total Valuation

LON:0VQA has a market cap or net worth of GBP 2.15 billion. The enterprise value is 1.51 billion.

Market Cap	2.15B
Enterprise Value	1.51B

Important Dates

The last earnings date was Wednesday, April 23, 2025.

Earnings Date	Apr 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+10.50%
Shares Change (QoQ)	+0.65%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	109.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.28
P/TBV Ratio	3.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.24
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 44.25, with a Debt / Equity ratio of 0.00.

Current Ratio	44.25
Quick Ratio	43.52
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,914.64

Financial Efficiency

Return on equity (ROE) is -14.40% and return on invested capital (ROIC) is -12.08%.

Return on Equity (ROE)	-14.40%
Return on Assets (ROA)	-11.74%
Return on Invested Capital (ROIC)	-12.08%
Return on Capital Employed (ROCE)	-20.33%
Revenue Per Employee	n/a
Profits Per Employee	-2.76M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-63.31%
50-Day Moving Average	27.25
200-Day Moving Average	47.49
Relative Strength Index (RSI)	53.14
Average Volume (20 Days)	16,821

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-133.37M
Pretax Income	-99.25M
Net Income	-99.25M
EBITDA	n/a
EBIT	-133.37M
Earnings Per Share (EPS)	-0.89

Balance Sheet

The company has 659.33 million in cash and 773,990 in debt, giving a net cash position of 658.56 million.

Cash & Cash Equivalents	659.33M
Total Debt	773,990
Net Cash	658.56M
Net Cash Per Share	n/a
Equity (Book Value)	655.51M
Book Value Per Share	5.88
Working Capital	655.14M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0VQA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.50%
Shareholder Yield	-10.50%
Earnings Yield	-4.61%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a